Status:
COMPLETED
Morbidity and Mortality of Hepatitis E Virus Infections in Belgium
Lead Sponsor:
University Hospital, Antwerp
Collaborating Sponsors:
Sciensano
KU Leuven
Conditions:
Hepatitis E
Eligibility:
All Genders
Brief Summary
Hepatitis E Virus (HEV) infections are emerging in the Western world with a predominance of HEV genotype (gt) 3. Except for age older than 50 years, male gender, chronic liver disease and immunosuppre...
Detailed Description
1. Study objectives 1.1. Primary objectives: To examine viral factors, such as gt, subtype and viral load, associated with the morbidity and mortality of HEV infections in Belgium. 1.2. Se...
Eligibility Criteria
Inclusion
- HEV RNA positive AND/OR HEV immunoglobulin (Ig)M positive
- Lab confirmation of the HEV infection performed at Sciensano
- All ages will be included
- Referring hospital in Belgium
Exclusion
- No confirmation of HEV serology AND/OR polymerase chain reaction (PCR) performed at Sciensano
- Cases not diagnosed in Belgium
- Cases without clinical outcome data
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2018
Estimated Enrollment :
280 Patients enrolled
Trial Details
Trial ID
NCT04670419
Start Date
January 1 2010
End Date
December 31 2018
Last Update
December 17 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.